LBRX NASDAQ
LB Pharmaceuticals Inc Common Stock
1W: -10.9%
1M: -11.9%
3M: +18.1%
YTD: +37.0%
$28.12
+0.12 (+0.43%)
After Hours: $28.27 (+0.15, +0.55%)
Weekly Expected Move ±6.5%
$26
$28
$30
$32
$34
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$806.4M
52W Range13.36-33.47
Volume143,948
Avg Volume248,571
Beta1.38
Dividend—
Analyst Ratings
Company Info
CEOHeather D. Turner
Employees16
SectorHealthcare
IndustryBiotechnology
IPO Date2025-09-11
Websitelbpharma.us
One Pennsylvania Plaza
New York, NY 10119
US
New York, NY 10119
US
212 605 0300
About LB Pharmaceuticals Inc Common Stock
Clinicalâstage biopharmaceutical company developing novel therapies for neuropsychiatric diseases (e.g. schizophrenia, bipolar depression). Lead candidate is LBâ102, a methylated derivative of amisulpride.
Latest News
This LB Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference
LB Pharmaceuticals Inc GAAP EPS of -$0.45
LB Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
LB Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Recent Insider Trades
No insider trades found